References

1. Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005;26: 178-82.

2. Walgren JL, Thompson DC. Application of proteomic technologies in the drug development process. Toxicol Lett 2004;149:377-85.

3. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640-3.

4. Westerhoff HV, Palsson BO. The evolution of molecular biology into systems biology. Nat Biotechnol 2004;22:1249-52.

5. van Ommen B. Nutrigenomics: exploiting systems biology in the nutrition and health arenas. Nutrition 2004;20:4-8.

6. Pevzner PA. Computational molecular biology. Cambridge: MIT Press, 2000.

7. Bower JM, Bolouri H, editors. Computational modeling of genetic and biochemical networks. Cambridge: MIT Press, 2001.

8. Wolkenhauer O. Systems biology: the reincarnation of systems theory applied in biology? Brief Bioinform 2001;2:258-70.

9. van der Greef J, Stroobant P, van der Heijden R. The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 2004;8:559-65.

10. Strange K. The end of "naive reductionism": rise of systems biology or renaissance of physiology? Am J Physiol Cell Physiol 2005;288:C968-74.

11. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158:20-9.

12. Siripurapu V, Meth J, Kobayashi N, Hamaguchi M. DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways. J Mol Biol 2005;346:83-9.

13. Itoh T, Karlsberg K, Kijima I, Yuan YC, Smith D, Ye J, et al. Letrozole-, anas-trozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol Cancer Res 2005;3:203-18.

14. Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G, et al. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol 2005;141:165-73.

15. Palsson BO. What lies beyond bioinformatics? Nat Biotechnol 1997;15:3-4.

16. Kitano H. Computational systems biology. Nature 2002;420:206-10.

17. Rousseau F, Schymkowitz J. A systems biology perspective on protein structural dynamics and signal transduction. Curr Opin Struct Biol 2005;15:23-30.

18. Cavalieri D, De Filippo C. Bioinformatic methods for integrating whole-genome expression results into cellular networks. Drug Discov Today 2005;10:727-34.

19. Wolf DM, Arkin AP. Motifs, modules and games in bacteria. Curr Opin Micro-biol 2003;6:125-34.

20. McAdams HH, Arkin AP. Gene regulation: towards a circuit engineering discipline. Curr Biol 2000;10:R318-R20.

21. Butte A. The use and analysis of microarray data. Nat Rev Drug Discov 2002;1:951-60.

22. Kauffman S. A proposal for using the ensemble approach to understand genetic regulatory networks. J Theor Biol 2004;230:581-90.

23. Begley TJ, Samson LD. Network responses to DNA damaging agents. DNA Repair (Amst) 2004;3:1123-32.

24. Mack GS. Can complexity be commercialized? Nat Biotechnol 2004;22: 1223-9.

25. Ekins S, Kirillov E, Rakhmatulin EA, Nikolskaya T. A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism. Drug Metab Dispos 2005;33:474-81.

26. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158:20-9.

27. Ekins S, Nikolsky Y, Nikolskaya T. Techniques: Application of systems biology to absorption, distribution, metabolism, excretion, and toxicity. Trends Pharmacol Sci 2005;26:202-9.

28. Ekins S, Boulanger B, Swaan PW, Hupcey MAZ. Towards a new age of virtual ADME/TOX and multidimensional drug discovery. J Comput Aided Mol Des 2002;16:381-401.

29. Ekins S, Bugrim A, Nikolsky Y, Nikolskaya T. Systems biology: applications in drug discovery. In: Gad S, editor, Drug discovery handbook. New York: Wiley, 2005. p. 123-183.

Christopher R, Dhiman A, Fox J, Gendelman R, Haberitcher T, Kagle D, et al. Data-driven computer simulation of human cancer cell. Ann NY Acad Sci 2004;1020:132-53.

Defranoux NA, Stokes CL, Young DL, Kahn AJ. In silico modeling and simulation of bone biology: a proposal. J Bone Miner Res 2005;20:1079-84. Plavec I, Sirenko O, Privat S, Wang Y, Dajee M, Melrose J, et al. Method for analyzing signaling networks in complex cellular systems. Proc Natl Acad Sci USA 2004;101:1223-8.

Butcher EC, Berg EL, Kunkel EJ. Systems biology in drug discovery. Nat Bio-technol 2004;22:1253-9.

Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, et al. Functional discovery via a compendium of expression profiles. Cell 2000;102:109-26.

Castle AL, Carver MP, Mendrick DL. Toxicogenomics: a new revolution in drug safety. Drug Discov Today 2002;7:728-36.

Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, et al. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 2005;119:219-44.

Natsoulis G, El Ghaoui L, Lanckriet GR, Tolley AM, Leroy F, Dunlea S, et al. Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res 2005;15:724-36.

Gunther EC, Stone DJ, Rothberg JM, Gerwien RW. A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action. Pharmacogenomics J 2005;5:126-34.

Hart CP. Finding the target after screening the phenotype. Drug Discov Today 2005;10:513-9.

Nikolsky Y, Nikolskaya T, Bugrim A. Biological networks and analysis of experimental data in drug discovery. Drug Discov Today 2005;10:653-62. Cabusora L, Sutton E, Fulmer A, Forst CV. Differential network expression during drug and stress response. Bioinformatics 2005;21:2898-905. Lu B, Soreghan BA, Thomas SN, Chen T, Yang AJ. Towards global proteomic analysis in a PS1/APP mouse of Alzheimer's disease. ACS. San Diego, 2005. Waters KM, Shankaran H, Wiley HS, Resat H, Thrall BD. Integration of micro-array and proteomics data for biological pathway analysis and network modeling of epidermal growth factor signaling in human mammary epithelial cells. Keystone Symposia, 2005.

Lantz RC, Petrick JS, Hays AM. Altered protein expression following in utero exposure to arsenic. Society of Toxicology, 2005.

Nie AY, McMillian MK, Leone AM, Parker JB, Piechta L-A, Bryant S, et al. A gene signature for non-genotoxic carcinogens. Society of Toxicology, 2005. Meng Q, Waters KM, Malard JM, Lee KM, Pounds JG. Gene expression modifications in a mouse emphysema model induced by elastase. Society of Toxicology, 2005.

Mason CW, Swaan PW, Weiner CP. Gene Array Profiling of myometrial events during pregnancy: unlocking the universe of gene interactions using gene maps and interactive networks. Society of Gynecological Investigation. Los Angeles, CA, 2005.

48. Weiner CP, Mason CW, Buhimschi C, Hall G, Swaan PW, Buhimschi I. Changes in uterine GTPase activity are not consistent with changes in expression of Ga subunits of heterotrimeric G-proteins: A potential mechanism for myometrial quiescence. Society of Gynecological Investigation. Los Angeles, CA, 2005.

49. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A. Reverse engineering of regulatory networks in human B cells. Nat Genet 2005;37:382-90.

50. McMillian M, Nie A, Parker JB, Leone A, Kemmerer M, Bryant S, et al. Drug-induced oxidative stress in rat liver from a toxicogenomics perspective. Toxicol Appl Pharmacol 2005;207:171-8.

51. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D, et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 2005;37:710-7.

52. Thongboonkerd V. Genomics, proteomics and integrative "omics" in hypertension research. Curr Opin Nephrol Hypertens 2005;14:133-9.

53. Ghazalpour A, Doss S, Yang X, Aten J, Toomey EM, Van Nas A, et al. Thematic review series: The pathogenesis of atherosclerosis. Toward a biological network for atherosclerosis. J Lipid Res 2004;45:1793-805.

54. Ekins S. Systems-ADME/Tox: Resources and network approaches. J Pharmacol Toxicol Methods 2006;53:38-66.

55. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, et al. Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 2005.

56. Raponi M, Belly RT, Karp JE, Lancet JE, Atkins D, Wang Y. Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia. BMC Cancer 2004;4:56.

57. Busold CH, Winter S, Hauser N, Bauer A, Dippon J, Hoheisel JD, et al. Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data. Bioinformatics 2005;21:2424-9.

58. FDA. Food and Drug Administration. Guidance for Industry, Pharmacoge-nomic Data Submissions. March 2005.

59. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003;19:524-31.

60. Sauro HM, Hucka M, Finney A, Wellock C, Bolouri H, Doyle J, et al. Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration. Omics 2003;7:355-72.

61. Fliri AF, Loging WT, Thadeio PF, Volkmann RA. Biological spectra analysis: Linking biological activity profiles to molecular structure. Proc Natl Acad Sci USA 2005;102:261-6.

62. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L. Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol 2004;5:763-9.

63. Kell DB. Metabolomics and systems biology: making sense of the soup. Curr Opin Microbiol 2004;7:296-307.

64. Cary MP, Bader GD, Sander C. Pathway information for systems biology. FEBS Lett 2005;579:1815-20.

65. Luciano JS. PAX of mind for pathway researchers. Drug Discov Today 2005;10:937-42.

66. Jenssen TK, Laegreid A, Komorowski J, Hovog E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001;28:21-8.

67. Krauthammer M, Kaufmann CA, Gilliam TC, Rzhetsky A. Molecular triangulation: bridging linkage and molecular-network information for identifying candidate genes in Alzheimer's disease. Proc Natl Acad Sci USA 2004;101: 15148-53.

68. Rzhetsky A, Iossifov I, Koike T, Krauthammer M, Kra P, Morris M, et al. GeneWays: a system for extracting, analyzing, visualizing, and integrating molecular pathway data. J Biomed Inform 2004;37:43-53.

69. Alako BT, Veldhoven A, van Baal S, Jelier R, Verhoeven S, Rullmann T, et al. CoPub Mapper: mining MEDLINE based on search term co-publication. BMC Bioinformatics 2005;6:51.

70. Gardner SP. Ontologies and semantic data integration. Drug Discov Today 2005;10:1001-7.

71. Krallinger M, Valencia A. Text-mining and information-retrieval services for molecular biology. Genome Biol 2005;6:224.

72. Douglas SM, Montelione GT, Gerstein M. PubNet: a flexible system for visualizing literature derived networks. Genome Biol 2005;6:R80.

73. Covitz PA, Hartel F, Schaefer C, De Coronado S, Fragoso G, Sahni H, et al. caCORE: a common infrastructure for cancer informatics. Bioinformatics 2003;19:2404-12.

74. Waters M, Boorman G, Bushel P, Cunningham M, Irwin R, Merrick A, et al. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base. EHP Toxicogenomics 2003;111:15-28.

75. Xirasagar S, Gustafson S, Merrick BA, Tomer KB, Stasiewicz S, Chan DD, et al. CEBS object model for systems biology data, SysBio-OM. Bioinformatics 2004;20:2004-15.

76. Fostel J, Choi D, Zwickl C, Morrison N, Rashid A, Hasan A, et al. Chemical Effects in Biological Systems—Data Dictionary (CEBS-DD): a compendium of terms for the capture and integration of biological study design description, conventional phenotypes and 'omics data. Toxicol Sci 2005;88:585-601.

77. Heath JR, Phelps ME, Hood L. NanoSystems biology. Mol Imaging Biol 2003;5:312-25.

78. Barabasi A-L, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004;5:101-13.

79. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, Li Y, et al. A protein interaction map of Drosophila melanogaster. Science 2003;302:1727-36.

80. de Menezes MA, Barabasi AL. Fluctuations in network dynamics. Phys Rev Lett 2004;92:028701.

81. Raser JM, O'Shea EK. Noise in gene expression: origins, consequences, and control. Science 2005;309:2010-3.

82. Oilman AG, Simon MI, Bourne HR, Harris BA, Long R, Ross EM, et al. Overview of the Alliance for Cellular Signaling. Nature 2002;420:703-6.

83. Wilson SH, Olden K. The environmental genome project: phase I and beyond. Mol Interv 2004;4:147-56.

84. Henry CJ. Evolution of toxicology for risk assessment. Int J Toxicol 2003;22: 3-7.

85. Werner E. Meeting report: the future and limits of systems biology. Sci STKE 2005; 2005:pe16.

86. McDaniel R, Weiss R. Advances in synthetic biology: on the path from prototypes to applications. Curr Opin Biotechnol 2005;16:476-83.

87. Kramer BP, Fischer C, Fussenegger M. BioLogic gates enable logical transcription control in mammalian cells. Biotechnol Bioeng 2004;87:478-84.

88. Lash LH, Hines RN, Gonzalez FJ, Zacharewski TR, Rothstein MA. Genetics and susceptibility to toxic chemicals: do you (or should you) know your genetic profile? J Pharmacol Exp Ther 2003;305:403-9.

89. Ekins S, Bugrim A, Nikolsky Y, Nikolskaya T. Systems biology: applications in drug discovery. In: Gad SC, editor, Drug discovery handbook. New York: Wiley, 2005. p. 123-83.

90. Ekins S, Kirillov E, Rakhmatulin E, Nikolskaya T. A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism. Drug Metab Dispos 2005;33:474-81.

91. Ekins S, Andreyev S, Ryabov A, Kirilov E, Rakhmatulin EA, Bugrim A, et al. Computational prediction of human drug metabolism. Exp Opin Drug Metab Toxicol 2005;1:303-24.

92. Ekins S, Giroux CN, Nikolsky Y, Bugrim A, Nikolskaya T. A signature gene network approach to toxicity. Toxicologist 2005 ;84.

93. Kasamatsu A, Endo Y, Uzawa K, Nakashima D, Koike H, Hashitani S, et al. Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses. Int J Biochem Cell Biol 2005;37:1869-80.

94. Zeng F, Schultz RM. RNA transcript profiling during zygotic gene activation in the preimplantation mouse embryo. Dev Biol 2005;283:40-57.

95. Paris D, Ait-Ghezala G, Mathura VS, Patel N, Quadros A, Laporte V, et al. Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells. Brain Res Mol Brain Res 2005;136:212-30.

96. Lee TS, Eid T, Mane S, Kim JH, Spencer DD, Ottersen OP, et al. Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy. Acta Neuropathol (Berl) 2004;108:493-502.

97. Chen YF, Shin SJ, Lin SR. Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells. DNA Cell Biol 2005;24: 126-32.

98. Daraselia N, Yuryev A, Egorov S, Novihkova S, Nikitin A, Mazo I. Extracting human protein interactions from Medline using a full-sentence parser. Bioinfor-matics 2003;19.

99. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio—the analysis and navigation of molecular networks. Bioinformatics 2003;19:2155-7.

Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, et al. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways. Oncogene 2004;23:8065-77. Yonan AL, Palmer AA, Smith KC, Feldman I, Lee HK, Yonan JM, et al. Bio-informatic analysis of autism positional candidate genes using biological databases and computational gene network prediction. Genes Brain Behav 2003;2: 303-20.

Breitkreutz BJ, Stark C, Tyers M. Osprey: a network visualization system. Genome Biol 2003;4:R22.

Funahashi A, Morohashi M, Kitano H, Tanimura N. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. BioSilico 2003;1:159-62.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cyto-scape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498-504.

Longabaugh WJ, Davidson EH, Bolouri H. Computational representation of developmental genetic regulatory networks. Dev Biol 2005;283:1-16.

Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, Surendra-

nath V, et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 2003;13:

2363-71.

Hu Z, Mellor J, Wu J, Yamada T, Holloway D, Delisi C. VisANT: data-integrating visual framework for biological networks and modules. Nucleic Acids Res 2005;33:W352-7.

Hu Z, Mellor J, Wu J, DeLisi C. VisANT: an online visualization and analysis tool for biological interaction data. BMC Bioinformatics 2004;5:17. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002;31:19-20.

Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: using Gene Ontology and GenMAPP to create a global geneexpression profile from microarray data. Genome Biol 2003;4:R7. Li Y, Hong X, Hussain M, Sarkar SH, Li R, Sarkar FH. Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol Cancer Ther 2005;4:389-98. Li Y, Hussain M, Sarkar SH, Eliason J, Li R, Sarkar FH. Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells. BMC Cancer 2005;5:7.

Ohnishi H, Asamoto M, Tujimura K, Hokaiwado N, Takahashi S, Ogawa K, et al. Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci 2004;95:936-42. Wang JM, Johnston PB, Ball BG, Brinton RD. The neurosteroid allopregnano-lone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J Neurosci 2005;25:4706-18.

115. Swagell CD, Henly DC, Morris CP. Expression analysis of a human hepatic cell line in response to palmitate. Biochem Biophys Res Commun 2005;328:432-41.

116. Luo W, Fan W, Xie H, Jing L, Ricicki E, Vouros P, et al. Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. Chem Res Toxicol 2005;18:619-29.

117. Krikun G, Schatz F, Taylor R, Critchley HO, Rogers PA, Huang J, et al. Endo-metrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab 2005;90:1812-8.

118. Ise R, Han D, Takahashi Y, Terasaka S, Inoue A, Tanji M, et al. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 2005;579:1732-40.

119. Punyadeera C, Dassen H, Klomp J, Dunselman G, Kamps R, Dijcks F, et al. Oestrogen-modulated gene expression in the human endometrium. Cell Mol Life Sci 2005;62:239-50.

120. McKallip RJ, Nagarkatti M, Nagarkatti PS. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 2005;174:3281-9.

PART III

SCIENTIFIC INFORMATION HANDLING AND ENHANCING PRODUCTIVITY

Unraveling Alzheimers Disease

Unraveling Alzheimers Disease

I leave absolutely nothing out! Everything that I learned about Alzheimer’s I share with you. This is the most comprehensive report on Alzheimer’s you will ever read. No stone is left unturned in this comprehensive report.

Get My Free Ebook


Post a comment